Patents by Inventor Karin Rimvall

Karin Rimvall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of treating steroid-induced obesity using GLP-1 agonists
    Patent number: 8853157
    Abstract: The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
    Type: Grant
    Filed: February 26, 2013
    Date of Patent: October 7, 2014
    Assignee: Novo Nordisk A/S
    Inventors: Sanne Moeller Knudsen, Karin Rimvall
  • Counteracting drug-induced obesity using GLP-1 agonists
    Patent number: 8410047
    Abstract: The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
    Type: Grant
    Filed: May 31, 2005
    Date of Patent: April 2, 2013
    Assignee: Novo Nordisk A/S
    Inventors: Camilla Bock, Sanne Møller Knudsen, Karin Rimvall
  • Counteracting Drug-Induced Obesity Using GLP-1 Agonists
    Publication number: 20090054315
    Abstract: The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
    Type: Application
    Filed: May 31, 2005
    Publication date: February 26, 2009
    Applicant: NOVO VORDISK A/S
    Inventors: Camilla Bock, Sanne Moller Knudsen, Karin Rimvall